MacroGenics
MGNX
HK$10.36
Share price
0.76%
Change (1 day)
-70.51%
Change (1 year)
Categories
Market capitalization of MacroGenics (MGNX)
Market cap: HK$0.65 Billion
As of June 2025 MacroGenics has a market cap of HK$0.65 Billion. This makes MacroGenics the world's 9307th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of MacroGenics from 2020 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$0.65 B | -58.47% |
| 2024 | HK$1.57 B | -66.23% |
| 2023 | HK$4.66 B | 44.6% |
| 2022 | HK$3.22 B | -57.99% |
| 2021 | HK$7.67 B | -23.02% |
| 2020 | HK$9.96 B |
End of Day market cap according to different sources
On Jun 23rd, 2025 the market cap of MacroGenics was reported to be:
HK$0.65 Billion
HK$0.65 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | HK$4.69 B | 618.72% | 🇺🇸 USA |
 Pfizer PFE | HK$1.072 T | 163,949.90% | 🇺🇸 USA |
 Merck MRK | HK$1.579 T | 241,598.02% | 🇺🇸 USA |
 Gilead Sciences GILD | HK$1.036 T | 158,514.55% | 🇺🇸 USA |
 Amgen AMGN | HK$1.149 T | 175,805.41% | 🇺🇸 USA |
 Eli Lilly LLY | HK$5.430 T | 830,637.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$749.51 B | 114,557.61% | 🇺🇸 USA |